Bridge linkage role played by CD98hc of anti-tumor drug resistance and cancer metastasis on cisplatin-resistant ovarian cancer cells

Cancer Biology and Therapy

Volumn 6, Issue 6, 2007, Pages 942-947

  Yang, Hong ^a   Zou, Wei ^a   Li, Yu ^b   Chen, Biliang ^a   Xin, Xiaoyan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cancer metastasis; CD147; CD98 heavy chain; Multi drug resistance; P glycoprotein

Indexed keywords

ANTINEOPLASTIC AGENT; CD147 ANTIGEN; CD98 ANTIGEN; CISPLATIN; GLYCOPROTEIN P; LUCIFERASE; MULTIDRUG RESISTANCE PROTEIN 1;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL DISRUPTION; CONTROLLED STUDY; DRUG ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; METASTASIS; MOLECULAR CLONING; OVARY CANCER; PROMOTER REGION; PROTEIN EXPRESSION; RNA INTERFERENCE; BIOLOGICAL MODEL; CHEMISTRY; DRUG RESISTANCE; FEMALE; IC 50; METABOLISM; OVARY TUMOR; PATHOLOGY; PROTEIN SYNTHESIS; TUMOR CELL LINE;

ANTIGENS, CD147; ANTIGENS, CD98; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; MODELS, GENETIC; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; P-GLYCOPROTEIN; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS;

EID: 42449100821     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.6.4190     Document Type: Article

References (34)

1. Nabeshima K, Iwasaki H, Koga K, Hojo H, Suzumiya J, Kikuchi M. Emmprin (basigin/CD147): Matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 2006; 56:359-67.
2. Zou W, Yang H, Hou X, Zhang W, Chen B, Xin X. Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells. Cancer Lett 2007; 248:211-8.
3. Hait WN, Yang JM. Clinical management of recurrent breast cancer: Development of multidrug resistance (MDR) and strategies to circumvent it. Semin Oncol 2005; 32:S16-21.
4. Yakirevich E, Sabo E, Naroditsky I, Sova Y, Lavie O, Resnick MB. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas. Gynecol Oncol 2006; 100:152-9.
5. Ghadjar P, Coupland SE, Na IK, Noutsias M, Letsch A, Stroux A, Bauer S, Buhr HJ, Thiel E, Scheibenbogen C, Keilholz U. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J Clin Oncol 2006; 24:1910-6.
6. Nakatani K, Wada T, Nakamura M, Uzawa K, Tanzawa H, Fujita S. Expression of caveolin-1 and its correlation with cisplatin sensitivity in oral squamous cell carcinoma. J Cancer Res Clin Oncol 2005; 131:445-52.
7. Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. Cancer Res 2004; 64:3987-93.
8. Scotto KW. Transcriptional regulation of ABC drug transporters. Oncogene 2003;22:7496-511.
9. Mahadevan D, List AF. Targeting the multidrug resistance-1 transporter in AML: Molecular regulation and therapeutic strategies. Blood 2004; 104:1940-51.
10. Gottesman MM, Ling V. The molecular basis of multidrug resistance in cancer: The early years of P-glycoprotein research. FEBS Lett 2006; 580:998-1009.
11. Chambers TC, McAvoy EM, Jacobs JW, Eilon G. Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J Biol Chem 1990;265:7679-86.
12. Chaudhary PM, Roninson IB. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. Oncol Res 1992; 4:281-90.
13. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995; 55:434-9.
14. Jiang JL, Zhou Q, Yu MK, Ho LS, Chen ZN, Chan HC. The involvement of HAb18G/CD147 in regulation of store-operated calcium entry and metastasis of human hepatoma cells. J Biol Chem 2001; 276:46870-7.
15. Davidson B, Givant-Horwitz V, Lazarovici P, Risberg B, Nesland JM, Trope CG, Schaefer E, Reich R. Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): Co-expression in metastatic serous ovarian carcinoma. Clin Exp Metastasis 2003; 20:621-31.
16. Muramatsu T, Miyauchi T. Basigin (CD147): A multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion. Histol Histopathol 2003; 18:981-7.
17. Pushkarsky T, Zybarth G, Dubrovsky L, Yurchenko V, Tang H, Guo H, Toole B, Sherry B, Bukrinsky M. CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proc Natl Acad Sci USA 2001; 98:6360-5.
18. Bellone G, Alloatti G, Levi R, Geuna M, Tetta C, Peruzzi L, Letarte M, Malavasi F. Identification of a new epitope of the 4F2/44D7 molecular complex present on sarcolemma and isolated cardiac fibers. Eur J Immunol 1989; 19:1-8.
19. Dixon WT, Sikora LK, Demetrick DJ, Jerry LM. Isolation and characterization of a heterodimeric surface antigen on human melanoma cells and evidence that it is the 4F2 cell activation/proliferation molecule. Int J Cancer 1990; 45:59-68.
20. Esteban F, Ruiz-Cabello F, Concha A, Perez Ayala M, Delgado M, Garrido F. Relationship of 4F2 antigen with local growth and metastatic potential of squamous cell carcinoma of the larynx. Cancer 1990; 66:1493-8.
21. Yoon JH, Kim YB, Kanai Y, Endou H, Kim DK. Sequential increases in 4F2hc expression during DMBA-induced hamster buccal pouch carcinogenesis. Anticancer Res 2003;23:3877-81.
22. Deves R, Boyd CA. Surface antigen CD98(4F2): Not a single membrane protein, but a family of proteins with multiple functions. J Membr Biol 2000; 173:165-77.
23. Verrey F, Closs EI, Wagner CA, Palacin M, Endou H, Kanai Y. CATs and HATs: The SLC7 family of amino acid transporters. Pflugers Arch 2004; 447:532-42.
24. Xu D, Hemler ME. Metabolic activation-related CD147-CD98 complex. Mol Cell Proteomics 2005; 4:1061-71.
25. Yang JM, Xu Z, Wu H, Zhu H, Wu X, Hait WN. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res 2003;1:420-7.
26. Li Y, Shang P, Qian AR, Wang L, Yang Y, Chen ZN. Inhibitory effects of antisense RNA of HAb18G/CD147 on invasion of hepatocellular carcinoma cells in vitro. World J Gastroenterol 2003; 9:2174-7.
27. Liang Q, Xiong H, Gao G, Xiong K, Wang X, Zhao Z, Zhang H, Li Y. Inhibition of basigin expression in glioblastoma cell line via antisense RNA reduces tumor cell invasion and angiogenesis. Cancer Biol Ther 2005; 4:759-62.
28. Ho R, Eggert A, Hishiki T, Minturn JE, Ikegaki N, Foster P, Camoratto AM, Evans AE, Brodeur GM. Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res 2002; 62:6462-6.
29. Haluska P, Carboni JM, Loegering DA, Lee FY, Wittman M, Saulnier MG, Frennesson DB, Kalli KR, Conover CA, Attar RM, Kaufmann SH, Gottardis M, Erlichman C. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417. Cancer Res 2006; 66:362-71.
30. Molinari A, Stringaro A, Gentile M, Colone M, Toccacieli L, Arancia G. Invasive properties of multidrug resistant human melanoma cells. Ital J Anat Embryol 2005; 110:135-41.
31. Fan J, Frey RS, Malik AB. TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J Clin Invest 2003; 112:1234-43.
32. Drozina G, Kohoutek J, Jabrane-Ferrat N, Peterlin BM. Expression of MHC II genes. Curr Top Microbiol Immunol 2005; 290:147-70.
33. Parmacek MS, Karpinski BA, Gottesdiener KM, Thompson CB, Leiden JM. Structure, expression and regulation of the murine 4F2 heavy chain. Nucleic Acids Res 1989;17:1915-31.
34. Henderson NC, Collis EA, Mackinnon AC, Simpson KJ, Haslett C, Zent R, Ginsberg M, Sethi T. CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation. J Biol Chem 2004; 279:54731-41.